Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | 197.64% | 162.16% | 119.13% | 15.06% | -16.53% |
| Total Depreciation and Amortization | -73.30% | -51.50% | -35.61% | -22.01% | -11.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | -52.11% | -17.11% | 425.59% | 176.46% | 182.55% |
| Change in Net Operating Assets | -1,931.96% | -564.25% | -241.95% | -16.72% | -326.94% |
| Cash from Operations | 79.05% | 37.69% | 20.62% | 12.34% | -7.89% |
| Capital Expenditure | 100.00% | 100.00% | 81.82% | 95.24% | 69.70% |
| Sale of Property, Plant, and Equipment | 100.00% | -- | -- | -- | -200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 423.85% | 52.13% | 72.08% | 52.32% | 50.91% |
| Cash from Investing | 423.22% | 52.30% | 72.09% | 52.44% | 50.94% |
| Total Debt Issued | -- | -- | -- | -206.68% | -200.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -99.01% | -100.00% | -100.00% | -90.34% | -90.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48,584.62% | -100.00% | -100.00% | -100.09% | -100.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.10% | -181.92% | -187.98% | -186.00% | -185.57% |